![](/img/cover-not-exists.png)
Asymptomatic screening for SARS CoV-2 prior to commencement of biologic therapies in patients with inflammatory bowel disease - a potentially harmful practice.
Prentice, Ralley E., Al-Ani, Aysha H, Bond, Katherine, Johnson, Doug, Christensen, BrittJournal:
Digestive and Liver Disease
DOI:
10.1016/j.dld.2020.08.035
Date:
August, 2020
File:
PDF, 208 KB
2020